Genus (LON:GNS) Posts Earnings Results

Genus (LON:GNS) released its quarterly earnings results on Thursday. The company reported GBX 110.30 earnings per share for the quarter, Digital Look Earnings reports. Genus had a return on equity of 9.70% and a net margin of 7.07%.

Here are the key takeaways from Genus’ conference call:

• FY 2026 results were strong: adjusted profit before tax and adjusted EPS each rose 35%, while free cash flow increased to £62 million and leverage fell to 0.4x.
• Genus announced a £60 million share buyback for FY 2027 and recommended a 10% increase in the full-year dividend to 35.2 pence per share, reflecting confidence in cash generation and future growth.
• PIC delivered broad-based growth, including 52% royalty-revenue growth in China and market-share gains, while the new China joint venture is expected to support further expansion in the world’s largest porcine market.
• PRP regulatory progress continued with approvals or favorable determinations in Argentina, Canada, Uruguay, and Peru; commercialization is now beginning in selected Latin American markets, although approvals in Mexico and China remain pending.
• Management expects FY 2027 underlying adjusted profit before tax to be only moderately higher, with growth weighted toward the second half due to weak agricultural markets, North American disease pressures, lower Brazilian growth, depressed dairy conditions, and higher PRP and product-development costs.

Genus Price Performance

LON GNS traded down GBX 114 during mid-day trading on Thursday, hitting GBX 2,120. The stock had a trading volume of 1,523,460 shares, compared to its average volume of 775,327. The company has a 50 day simple moving average of GBX 2,223.11 and a 200 day simple moving average of GBX 2,382.24. The company has a market cap of £1.41 billion, a price-to-earnings ratio of 29.86, a P/E/G ratio of 2.87 and a beta of 0.90. Genus has a 52-week low of GBX 1,943 and a 52-week high of GBX 3,220. The company has a quick ratio of 1.08, a current ratio of 2.25 and a debt-to-equity ratio of 51.73.

Insiders Place Their Bets

In other news, insider Celia Baxter purchased 2,336 shares of the company’s stock in a transaction dated Friday, June 26th. The stock was acquired at an average price of GBX 2,140 per share, for a total transaction of £49,990.40. Company insiders own 0.71% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Berenberg Bank reiterated a “buy” rating and set a GBX 3,350 price objective on shares of Genus in a research note on Thursday. Three analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of GBX 3,216.67.

About Genus

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands.